These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36374864)

  • 1. Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice.
    Muhamad N; Plengsuriyakarn T; Na-Bangchang K
    PLoS One; 2022; 17(11):e0277614. PubMed ID: 36374864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability and biodistribution of atractylodin encapsulated in PLGA nanoparticle in cholangiocarcinoma.
    Omar AI; Plengsuriyakarn T; Chittasupho C; Na-Bangchang K
    Clin Exp Pharmacol Physiol; 2021 Mar; 48(3):318-328. PubMed ID: 33125766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Analysis of Prognostic Factors in Patients With Advanced-Stage Intrahepatic Cholangiocarcinoma Following the Administration of Capsule Formulation of the Standardized Extract of
    Saeheng T; Karbwang J; Cheomung A; Tongsiri N; Plengsuriyakarn T; Na-Bangchang K
    Integr Cancer Ther; 2024; 23():15347354231223967. PubMed ID: 38291969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC.
    Plengsuriyakarn T; Kotawong K; Karbwang J; Na-Bangchang K
    BMC Complement Med Ther; 2023 Jun; 23(1):186. PubMed ID: 37287012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway.
    Vanaroj P; Chaijaroenkul W; Na-Bangchang K
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):551-558. PubMed ID: 36853304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways.
    Acharya B; Chaijaroenkul W; Na-Bangchang K
    J Pharm Pharmacol; 2021 Aug; 73(9):1191-1200. PubMed ID: 33885818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects.
    Kulma I; Panrit L; Plengsuriyakarn T; Chaijaroenkul W; Warathumpitak S; Na-Bangchang K
    BMC Complement Med Ther; 2021 Feb; 21(1):61. PubMed ID: 33579265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review.
    Na-Bangchang K; Plengsuriyakarn T; Karbwang J
    Planta Med; 2023 Jan; 89(1):3-18. PubMed ID: 35468650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models.
    Plengsuriyakarn T; Viyanant V; Eursitthichai V; Picha P; Kupradinun P; Itharat A; Na-Bangchang K
    BMC Complement Altern Med; 2012 Mar; 12():23. PubMed ID: 22448640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.
    Muhamad N; Plengsuriyakarn T; Chittasupho C; Na-Bangchang K
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):935-941. PubMed ID: 32334453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of
    Na-Bangchang K; Kulma I; Plengsuriyakarn T; Tharavanij T; Kotawng K; Chemung A; Muhamad N; Karbwang J
    J Tradit Complement Med; 2021 Jul; 11(4):343-355. PubMed ID: 34195029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Cholangiocarcinoma Cell Growth and Proliferation by Atractylodes lancea (Thunb) DC. through ERK-Signaling Cascade.
    Martviset P; Panrit L; Chantree P; Muhamad P; Na-Bangchang K
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3633-3640. PubMed ID: 34837922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug Interactions.
    Thiengsusuk A; Plengsuriyakarn T; Na-Bangchang K
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Activity of Atractylodes lancea (Thunb.) DC in a Hamster Model and Application of PET-CT for Early Detection and Monitoring Progression of Cholangiocarcinoma.
    Plengsuriyakarn T; Matsuda N; Karbwang J; Viyanant V; Hirayama K; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(15):6279-84. PubMed ID: 26434829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats.
    Wang XS; Hu XC; Chen GL; Yuan X; Yang RN; Liang S; Ren J; Sun JC; Kong GQ; Gao SG; Feng XS
    Phytother Res; 2015 Mar; 29(3):366-72. PubMed ID: 25447838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Activities of Thai Medicinal Plants with Promising Activities Against Malaria and Cholangiocarcinoma on Human Cytochrome P450.
    Sumsakul W; Mahavorasirikul W; Na-Bangchang K
    Phytother Res; 2015 Dec; 29(12):1926-33. PubMed ID: 26490449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
    Vaghela M; Sahu N; Kharkar P; Pandita N
    Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R; Bhateria M; Singh R; Bhatta RS
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borneol influences the pharmacokinetics of florfenicol through regulation of cytochrome P450 1A2 (CYP1A2), CYP2C11, CYP3A1, and multidrug resistance 1 (MDR1) mRNA expression levels in rats.
    Li X; Li S; Wang B; Zhang M; Yuan D; Li J; Liang G
    J Vet Med Sci; 2021 Aug; 83(8):1338-1344. PubMed ID: 34176823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin.
    Sumsakul W; Plengsuriyakarn T; Na-Bangchang K
    BMC Pharmacol Toxicol; 2016 Nov; 17(1):50. PubMed ID: 27839515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.